Ignite Creation Date:
2025-12-24 @ 12:56 PM
Ignite Modification Date:
2026-04-18 @ 11:00 PM
Study NCT ID:
NCT01918761
Status:
TERMINATED
Last Update Posted:
2019-12-30
First Post:
2013-05-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
Sponsor:
Central European Cooperative Oncology Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CECOG/ NSCLC.1.1.001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None